Thomas Cash

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Pediatric blood & cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Cash, Hunter C Jonus, Maya Tsvetkova, Jan H Beumer, Arhanti Sadanand, Jasmine Y Lee, Curtis J Henry, Dolly Aguilera, R Donald Harvey, Kelly C Goldsmith
A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors. Pediatric blood & cancer (2023)
Adam J Esbenshade, Lisa S Kahalley, Birte Wistinghausen, Thomas Cash, Reto M Baertschiger, Sara Zarnegar, Adam Green, Girish Dhall, null null
Children's Oncology Group's 2023 blueprint for research: Young investigators. Pediatric blood & cancer (2023)
Thomas Cash, Mark D Krailo, Allen B Buxton, Bruce R Pawel, John H Healey, Odion Binitie, Karen J Marcus, Holcombe E Grier, Patrick J Grohar, Damon R Reed, Aaron R Weiss, Richard G Gorlick, Katherine A Janeway, Steven G DuBois, Richard B Womer
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sara M Federico, Thomas Cash
A bridge over troubled water-Extending induction for high-risk neuroblastoma patients with poor end-of-induction response. Cancer 128 (15) (2022)
Pratik A Patel, Nicholas P DeGroote, Kasey Jackson, Thomas Cash, Sharon M Castellino, Preeti Jaggi, Adam J Esbenshade, Tamara P Miller
Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia. Cancer 128 (23) (2022)
Thomas Cash, Elizabeth Fox, Xiaowei Liu, Charles G Minard, Joel M Reid, Adrienne C Scheck, Brenda J Weigel, Cynthia Wetmore
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515). Pediatric blood & cancer 68 (9) (2021)
Muna Qayed, Thomas Cash, Mourad Tighiouart, Tobey J MacDonald, Kelly C Goldsmith, Rachel Tanos, Leslie Kean, Benjamin Watkins, Yvonne Suessmuth, Cynthia Wetmore, Howard M Katzenstein
A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors. Pediatric blood & cancer 67 (4) (2019)
Thomas Cash, Hong Yin, Courtney McCracken, Zhi Geng, Steven G DuBois, Bahig M Shehata, Thomas A Olson, Howard M Katzenstein, Cynthia Wetmore
Correlation of Ezrin Expression Pattern and Clinical Outcomes in Ewing Sarcoma. Sarcoma 2017 (2017)